BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32860461)

  • 1. Case report: SARS-CoV-2-induced urticaria or just a concomitance?
    Fida M; Mala R; Pupo L; Dibra A; Nasto K
    Dermatol Ther; 2020 Nov; 33(6):e14250. PubMed ID: 32860461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urticaria in an infant with SARS-CoV-2 positivity.
    Proietti I; Mambrin A; Bernardini N; Tolino E; Balduzzi V; Maddalena P; Marchesiello A; Michelini S; Volpe S; Skroza N; Potenza C
    Dermatol Ther; 2020 Nov; 33(6):e14043. PubMed ID: 32697027
    [No Abstract]   [Full Text] [Related]  

  • 3. What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2?
    Criado PR; Pagliari C; Criado RFJ; Marques GF; Belda W
    Dermatol Ther; 2020 Nov; 33(6):e14068. PubMed ID: 32713127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous lesions and COVID-19: Cystic painful lesion in a case with positive SARS-CoV-2.
    Goudarzi S; Dehghani Firouzabadi F; Dehghani Firouzabadi M; Rezaei N
    Dermatol Ther; 2020 Nov; 33(6):e14266. PubMed ID: 32882081
    [No Abstract]   [Full Text] [Related]  

  • 5. Alopecia areata in a patient with SARS-Cov-2 infection.
    Sgubbi P; Savoia F; Calderoni O; Longo R; Stinchi C; Tabanelli M
    Dermatol Ther; 2020 Nov; 33(6):e14295. PubMed ID: 32909635
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
    Pezzarossa E; Ungari M; Caresana G; Sagradi F; Cimardi L; Pan A; Testa S; Aguggini S; Varotti E; Tanzi G; Manotti L; Ferrero G; Gusolfino MD; Trombatore M;
    Am J Dermatopathol; 2021 May; 43(5):342-348. PubMed ID: 33405402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute urticaria preceding other COVID-19-associated manifestations-A case report.
    Chen V; Escandon Brehm J; Bellodi Schmidt F
    Pediatr Dermatol; 2021 Mar; 38(2):455-457. PubMed ID: 33410205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urticaria in the times of COVID-19.
    Kaushik A; Parsad D; Kumaran MS
    Dermatol Ther; 2020 Nov; 33(6):e13817. PubMed ID: 32531079
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacterial co-infections with SARS-CoV-2.
    Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
    IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated maculopapular eruption localized to head and neck: A cutaneous sign of COVID-19 infection.
    Farabi B; Atak MF
    Dermatol Ther; 2020 Nov; 33(6):e14468. PubMed ID: 33112023
    [No Abstract]   [Full Text] [Related]  

  • 11. Urticaria as a first clinical manifestation of COVID-19.
    Veraldi S; Romagnuolo M; Benzecry V
    Eur J Dermatol; 2020 Dec; 30(6):737-738. PubMed ID: 33459263
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronavirus disease 2019 and epidermolysis bullosa: Report of three cases.
    Abdollahimajd F; Youssefian L; Pourani MR; Vahidnezhad H; Uitto J
    Dermatol Ther; 2020 Nov; 33(6):e14194. PubMed ID: 32794270
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe urticarial rash as the initial symptom of COVID-19 infection.
    Pagali S; Parikh RS
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33766974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment.
    Martinez MA
    Front Immunol; 2021; 12():635371. PubMed ID: 33777024
    [No Abstract]   [Full Text] [Related]  

  • 16. Onychomadesis following COVID-19 infection: Is there a relationship?
    Senturk N; Ozdemir H
    Dermatol Ther; 2020 Nov; 33(6):e14309. PubMed ID: 32935910
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
    Majumder J; Minko T
    AAPS J; 2021 Jan; 23(1):14. PubMed ID: 33400058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urticaria and COVID-19: A review.
    Algaadi SA
    Dermatol Ther; 2020 Nov; 33(6):e14290. PubMed ID: 32902087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urticarial eruption in coronavirus disease 2019 infection: a case report in Tangerang, Indonesia.
    Gunawan C; Angela A; Widysanto A
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e372-e373. PubMed ID: 32386435
    [No Abstract]   [Full Text] [Related]  

  • 20. From SARS-CoV-2 hematogenous spreading to endothelial dysfunction: clinical-histopathological study of cutaneous signs of COVID-19.
    Patrì A; Vargas M; Buonanno P; Annunziata MC; Russo D; Staibano S; Servillo G; Fabbrocini G
    Diagn Pathol; 2021 Feb; 16(1):16. PubMed ID: 33632250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.